All Stories

GSK kicks off Blenrep's market return with first myeloma combo nod in UK

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022.

Apr 17, 2025 - 20:42
 0
GSK kicks off Blenrep's market return with first myeloma combo nod in UK
GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022.
Read More

Tags:

Previous Article

Hermès Bags Nearly $5 Billion in Q1 2025 Revenue as LVMH Struggles in Luxury Ret...

Next Article

Defense Innovation Unit seeks undersea drone capable of ‘long-range’ payload dep...

Related Posts

Bayer brings heart health message to Super Bowl, warning millennials to open their eyes to risks

Bayer brings heart health message to Super Bowl, warnin...

Feb 11, 2025  0

Regulatory tracker: Roche's Gazyva under FDA review in lupus nephritis

Regulatory tracker: Roche's Gazyva under FDA review in ...

Mar 5, 2025  0

Regulatory tracker: Gilead's seladelpar nabs EU approval in primary biliary cholangitis

Regulatory tracker: Gilead's seladelpar nabs EU approva...

Feb 21, 2025  0